Kistler-Tiffany Companies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Kistler-Tiffany Companies’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$271K	Hold	3,259	–	–	0.04%	289
2023 Q1	$248K	Sell	3,259 -800	-20%	-$66.4K	0.05%	262
2022 Q4	$337K	Sell	4,059 -515	-11%	-$41.7K	0.07%	182
2022 Q3	$363K	Hold	4,574	–	–	0.08%	153
2022 Q2	$340K	Sell	4,574 -48	-1%	-$3.6K	0.07%	156
2022 Q1	$415K	Hold	4,622	–	–	0.08%	151
2021 Q4	$517K	Sell	4,622 -395	-8%	-$47.6K	0.1%	119
2021 Q3	$631K	Sell	5,017 -714	-12%	-$91.9K	0.14%	93
2021 Q2	$776K	Sell	5,731 -515	-8%	-$67.7K	0.18%	87
2021 Q1	$847K	Hold	6,246	–	–	0.22%	80
2020 Q4	$879K	Sell	6,246 -255	-4%	-$32.7K	0.25%	68
2020 Q3	$724K	Buy	6,501 +609	+10%	+$68.3K	0.23%	71
2020 Q2	$660K	Buy	5,892 +2,778	+89%	+$274K	0.23%	69
2020 Q1	$296K	Hold	3,114	–	–	0.1%	113
2019 Q4	$296K	Buy	+3,114	New	+$269K	0.1%	117
2018 Q2	–	Sell	-609	Closed	-$53K	–	608
2018 Q1	$53K	Hold	609	–	–	0.02%	268
2017 Q4	$52K	Hold	609	–	–	0.02%	281
2017 Q3	$53K	Buy	+609	New	+$48.8K	0.02%	265
2016 Q4	–	Sell	-669	Closed	-$44K	–	546
2016 Q3	$44K	Hold	669	–	–	0.02%	269
2016 Q2	$36K	Hold	669	–	–	0.02%	293
2016 Q1	$35K	Buy	669 +149	+29%	+$7.74K	0.02%	290
2015 Q4	$122K	Hold	520	–	–	0.07%	168
2015 Q3	$108K	Sell	520 -89	-15%	-$7.01K	0.06%	180
2015 Q2	$51K	Sell	609 -636	-51%	-$49.5K	0.03%	255
2015 Q1	$94K	Hold	1,245	–	–	0.06%	179
2014 Q4	$77K	Hold	1,245	–	–	0.05%	196
2014 Q3	$65K	Hold	1,245	–	–	0.04%	215
2014 Q2	$64K	Buy	1,245 +234	+23%	+$10.6K	0.05%	202
2014 Q1	$48K	Hold	1,011	–	–	0.04%	232
2013 Q4	$44K	Hold	1,011	–	–	0.03%	248
2013 Q3	$44K	Hold	1,011	–	–	0.04%	244
2013 Q2	$35K	Buy	+1,011	New	+$35.5K	0.03%	260

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Kistler-Tiffany Companies's XBI Position: Q2 2023 in Review

Kistler-Tiffany Companies held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2023 at 3,259 shares worth $271K. The position accounts for 0.04% of the portfolio, ranked #289.

Kistler-Tiffany Companies first reported a position in XBI in Q2 2013 and has held it in 32 quarters since. The position peaked at $879K in Q4 2020. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Kistler-Tiffany Companies held 3,259 shares of State Street SPDR S&P Biotech ETF worth $271K as of Q2 2023.
Kistler-Tiffany Companies left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2023.
State Street SPDR S&P Biotech ETF made up 0.04% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #289 holding.
Kistler-Tiffany Companies first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 32 quarters since.
Kistler-Tiffany Companies's State Street SPDR S&P Biotech ETF position peaked at $879K in Q4 2020.
713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.